Infectious enteritis caused by bacterial pathogens are a significant global health concern, with high incidence and mortalities worldwide. The objective of this research was to explore the benefits of
Lactiplantibacillus plantarum CCNH185 against
Citrobacter rodentium-induced colitis in mice. Female C57BL/6J mice (
n = 8 per group) were orally administered
L. plantarum CCNH185 at a dose of 2 × 10
9 CFU daily for 24 days, followed by a single oral challenge with
C. rodentium (2 × 10
9 CFU) on day 21.
L. plantarum CCNH185 significantly alleviated disease symptoms including body weight loss, colon shortening and histopathological damage (
p < 0.05). Treatment with
L. plantarum CCNH185 also reduced pro-inflammatory cytokine levels, such as
IL-1β and
IL-6 (
p < 0.05), while increasing anti-inflammatory
IL-10 expression (
p < 0.05) in the colon. Histological and immunofluorescence demonstrated that
L. plantarum CCNH185 improved the intestinal barrier integrity by increasing goblet cell numbers, upregulating MUC2 expression, reducing crypt hyperplasia, and suppressing epithelial cell apoptosis. Furthermore, transcriptomic analysis revealed that
L. plantarum CCNH185 suppressed excessive immune cell infiltration and inflammatory responses in the colon during
C. rodentium infection. Flow cytometry analysis further confirmed that
L. plantarum CCNH185 suppressed hyperactivation of innate immune cells including macrophages, dendritic cells, neutrophils to alleviate inflammation. Furthermore,
L. plantarum CCNH185 reshaped the gut microbiota by increasing the abundance of beneficial genera such as
Lactobacillus,
Dubosiella, and
Romboutsia. Correlation analysis linked these microbial shifts with improved inflammatory and apoptotic markers. These findings highlight
L. plantarum CCNH185 may serve as a promising preventive probiotic candidate for ameliorating infectious colitis possibly through strengthening the gut mucus barrier, modulating immune responses, and altering gut microbiota composition.
Full article